Showing 1 - 7 results of 7 for search 'L. Albigès', query time: 0.05s Refine Results
  1. 1
    A phase 3 study (COSMIC-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk

    A phase 3 study (COSMIC-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poo... by T. Choueiri, L. Albiges, T. Powles, A. Geng, N. Mohamed, F. Wang, R.J. Motzer

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Elderly patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with Nivolumab (N): A subgroup analysis from the WITNESS real-world study in France

    Elderly patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with Nivolumab (N): A subgroup analysis from the WITNESS real-world study in France by P. Barthélémy, A. Thiery-Vuillemin, B. Escudier, J-C. Eymard, G. Mouillet, F. Schlürmann, M. Chartier, C. Quentric, Y-A. Vano, L. Albiges

    Published 2020-11-01
    Get full text
    Article
  3. 3
    Nephrectomy after complete response to immune checkpoint inhibitors for metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge?

    Nephrectomy after complete response to immune checkpoint inhibitors for metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge? by G. Pignot, A. Thiery-Vuillemin, J. Walz, H. Lang, P. Werle, L. Balssa, L. Geoffrois, L. Leblanc, L. Albigès, V. Di Nunno, K. Bensalah, S. Ladoire, G. Gravis, P. Barthélémy

    Published 2020-07-01
    Get full text
    Article
  4. 4
    Role of prior nephrectomy for synchronous metastatic Renal Cell Carcinoma (mRCC) on efficacy in patients treated with Avelumab + Axitinib (A + Ax) or Sunitinib (S): Results from JAVELIN Renal 101

    Role of prior nephrectomy for synchronous metastatic Renal Cell Carcinoma (mRCC) on efficacy in patients treated with Avelumab + Axitinib (A + Ax) or Sunitinib (S): Results from JA... by M-O. Grimm, M. Oya, T. Choueiri, M. Schmidinger, D.I. Quinn, G. Gravis-Mescam, E. Marseille, A.J.M. Van Den Eertwegh, A. Di Pietro, M. Mariani, J. Wang, D. Thomaidou, L. Albiges

    Published 2022-08-01
    Get full text
    Article
  5. 5
    Bias of available data makes it unreliable to compare outcomes of thermo-ablation versus surgery for the treatment of T1 renal tumours: A systematic review from the European Association of Urology Renal Cell Cancer Guideline Panel

    Bias of available data makes it unreliable to compare outcomes of thermo-ablation versus surgery for the treatment of T1 renal tumours: A systematic review from the European Associ... by Y. Abu-Ghanem, S. Fernández-Pello, A. Bex, B. Ljungberg, L. Albiges, S. Dabestani, R. Giles, F. Hofmann, M. Hora, M. Kuczyk, T. Kuusk, L. Marconi, A. Merseburger, R. Tahbaz, M. Staehler, A. Volpe, T. Powles, T. Lam, K. Bensalah

    Published 2020-07-01
    Get full text
    Article
  6. 6
    Management of sporadic renal angiomyolipomas. A systematic review of available evidence to guide recommendations from the EAU RCC Guidelines panel

    Management of sporadic renal angiomyolipomas. A systematic review of available evidence to guide recommendations from the EAU RCC Guidelines panel by S. Fernández-Pello Montes, T. Kuusk, M. Hora, R. Tahbaz, S. Dabestani, Y. Abu-Ghanem, L. Albiges, R. Giles, F. Hofmann, M. Kuczyk, T. Lam, L. Marconi, A. Merseburger, T. Powles, M. Staehler, A. Volpe, B. Ljungberg, A. Bex, K. Bensalah

    Published 2020-07-01
    Get full text
    Article
  7. 7
    IO-Synthesise RCC: A pooled analysis of real-world outcomes for advanced renal cell carcinoma patients treated with nivolumab in France and Germany

    IO-Synthesise RCC: A pooled analysis of real-world outcomes for advanced renal cell carcinoma patients treated with nivolumab in France and Germany by A. Thiery-Vuillemin, J. Bedke, L. Albigès, P. Bigot, B. Escudier, E. von der Heyde, V. Grünwald, H. Müller-Huesmann, B. Narciso, M. Schostak, W. Schultze-Seemann, Y-A. Vano, V. Allan, M. Chartier, M. Herber, L. McDonald, C. Quentric, P. Barthélémy, M-O. Grimm

    Published 2020-11-01
    Get full text
    Article

Search Tools: